跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMLODIPINO TAD 5 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AMLODIPINO TAD 5 MG COMPRIMIDOS EFG
Approved
STANDARD
AMLODIPINO TAD 5 MG COMPRIMIDOS EFG
Tad Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2022
Approval ID
d391ce836d17a1fd
Company
Tad Pharma Gmbh
Type
Standard
Approval Details
Approval Id
d391ce836d17a1fd
Drug Cima Aemps Name
AMLODIPINO TAD 5 MG COMPRIMIDOS EFG
Register Number
87992
Holder Company Name
Tad Pharma Gmbh
Marketing Company Name
Krka Farmaceutica S.L.
Holder Company Detail Path
/organization/tad-pharma-gmbh
Authorization Date
2022-07-21
Dosage Form
COMPRIMIDO
Dose
5 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
Yes
Company Name
Tad Pharma Gmbh
Company Detail Path
/organization/tad-pharma-gmbh
Company Information
Pharmaceutical Company Name
TAD Pharma GmbH
Country Name
Germany
City Name
cuxhaven,niedersachsen,country_de
Address
Heinz-Lohmann-Str. 5
Active Ingredients
AMLODIPINO BESILATO
6,94 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2022
Approval ID
d391ce836d17a1fd
Type
Standard
Back to CIMA-AEMPS Approvals